跳至主要内容
临床试验/NCT00377910
NCT00377910已完成4 期

Placebo Controlled Trial, Testing the Efficacy of Polidocanol Injections as a Treatment of Chronic Achilles Tendinopathy.

Northern Orthopaedic Division, Denmark1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2008年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
48
试验地点
1
主要终点
Pain during physical activity which usually causes pain

研究概览

简要总结

Chronic achilles tendinopathy is a common disease especially in adults. The golden standard in treatment has up to now been excentric exercises but with varying success. A new hypothesis is that this chronic pain is due to neo vascularisation. In a pilot study sclerosing injections with polidocanol have had a successful efficacy. Our aim is to study the efficacy of polidocanol as a treatment in a randomised controlled setting on a larger scale.

详细描述

48 patients with chronic achilles tendinopathy for more than 3 months who have tried excentric exercises without success will be randomised to either polidocanol or lidocaine injections if having ultrasound verified neo-vascularisation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 year old, Ultrasound verified Achilles tendinopathy with neo-vascularisation, pain duration more than three months, excentric exercises for at least three months, women: negative pregnancy test, safe anticonceptive

排除标准

  • Dementia, mental disease or other illness incompatible with participation, no ultrasound verified neo-vascularisation, any illness which contraindicate the use of Polidocanol or Lidocaine, granulation tissue of more than 50 % of the Achilles tendon, ability of lying in prone position, women: pregnancy or breastfeeding,

研究组 & 干预措施

2 drug

Placebo Comparator

injections of lidocaine

干预措施: Aethoxysclerol (Drug)

1, drug

Active Comparator

Injections of polidocanol

干预措施: Aethoxysclerol (Drug)

结局指标

主要结局

Pain during physical activity which usually causes pain

时间窗: 3 and 6 months

次要结局

  • Patient evaluation of treatment efficacy(3 and 6 months)
  • AOFAS(3 and 6 months)
  • Number of neo-vascularisation.(day 0, 1 and 3 months)
  • Achilles tendon pressure measuring until pain release.(3 and 6 months)
  • FAOS(3 and 6 months)
  • Pain while resting.(3 and 6 months)
  • Localisation of the neo-vascularisation(day 0, 1 and 3 months)

研究者

发起方
Northern Orthopaedic Division, Denmark
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验